Prospective Registry of Rivaroxaban Management of Cancer-Associated Venous Throboembolism (PRIMECAST) Study

Background: The incidence of thromboembolism in patients with cancer is approximately 11%, and the risk of thrombosis in patients with malignant tumors is 6-fold higher than that in healthy persons. Thrombosis not only disrupts the treatment of cancer but also induces deterioration of quality of lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Yuichi, Iwasa, Takeshi, Kumamaru, Hiraku, Miyata, Hiroaki, Mukai, Mikio, Shigematsu, Kunihiro, Shoji, Masaaki, Tanabe, Nobuhiro, Yamada, Norikazu, Yasuda, Chikao, Miyata, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2019
Materias:
Protocol Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897574/
https://www.ncbi.nlm.nih.gov/pubmed/33693097
http://dx.doi.org/10.1253/circrep.CR-19-0078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897574/
https://www.ncbi.nlm.nih.gov/pubmed/33693097
http://dx.doi.org/10.1253/circrep.CR-19-0078

Ejemplares similares